← Leaderboards
Richard Slivicki
Washington University
$518,470
Attributed
$518,470
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $165.9K · FY2020–25$200K$150K$100K$50K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$518,470 · 2
By mechanism
K99$331,822 · 1
F32$186,648 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Daniel Mamah$8,239,142
- Meaghan C Creed$6,854,312
- John P. Rice$13,697,998
- Michele L Pergadia$658,935
- Pablo M. Blazquez Gamez$2,985,980
Others in their field
Other Emerging Leaders on “Pharmacology”
- Leonard Freedman · Leidos Biomedical Research, Inc.$244,272,171
- Lynn Briscoe · Leidos Biomedical Research, Inc.$96,232,632
- Leonard Freedmand · Leidos Biomedical Research, Inc.$54,216,621
- Susan M Landau · University Of California Berkeley$47,252,026
- Jeffrey Reich · Sparian Biosciences, Inc.$28,575,028
- Michelle Lynn Sever · Rho Federal Systems Division, Inc.$26,732,375
Research focus
PharmacologyFutureOpioid OverdosePromoterNeuronsExperimental StudyGeneticOpioidPrescription OpioidTrainingPain DisorderBehaviorMentorsConditional KnockoutAffectiveConflict (Psychology)BaseAgonistDinoprostoneClinical TrialsCell Culture TechniquesCnr1 GeneCellsCb1 Knockout
Grant awards (5)
Functional and molecular characterization of the central amygdala in the context of oxycodone withdrawal$165,911
K99 · FY2025 · DA · contact PI
Functional and molecular characterization of the central amygdala in the context of oxycodone withdrawal$165,911
K99 · FY2024 · DA · contact PI
Evaluation of peripheral cannabinoid receptors as a target for pain management$55,332
F32 · FY2022 · DA · contact PI
Evaluation of peripheral cannabinoid receptors as a target for pain management$66,390
F32 · FY2021 · DA · contact PI
Evaluation of peripheral cannabinoid receptors as a target for pain management$64,926
F32 · FY2020 · DA · contact PI